Downregulation of PrPC caused by melatonin can prevent the expression of the stem cell markers Oct4, Nanog, Sox2 and ALDH1A1, which inhibits tumour development, proliferation and tumour-mediated angiogenesis by affecting ISCs [93]. Here, PRNP is linked to neoplasm.